Calamos Advisors
LVACU

Calamos Advisors’s LAVA Medtech Acquisition Corp. Unit LVACU Stock Holding History

Calamos Advisors’s Portfolio LVACU Stock Details LVACU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-25,000
Closed -$251K – 1591
2022
Q2 		$251K Hold
25,000
– – ﹤0.01% 1107
2022
Q1 		$253K Hold
25,000
– – ﹤0.01% 1109
2021
Q4 		$262K Buy
+25,000
New +$253K ﹤0.01% 1075

Other funds holding LVACU

CCA
Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return
BCM
Basso Capital Management Stamford, Connecticut $163M AUM 21.95% 1-Year Est. Return
CIM
Cowen Investment Management New York $12M AUM 1.47% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
WC
Wealthspring Capital West Harrison, New York $448M AUM 8.38% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
CCM
Condor Capital Management Martinsville, New Jersey $1.2B AUM 13.18% 1-Year Est. Return

Calamos Advisors's LVACU Position: Q3 2022 in Review

Calamos Advisors sold out of LAVA Medtech Acquisition Corp. Unit (LVACU) in Q3 2022, closing a stake of 25,000 shares — an estimated $251K sold.

Calamos Advisors first reported a position in LVACU in Q4 2021 and held it in 3 quarters. The position peaked at $262K in Q4 2021. 11 funds tracked by Wall St. Rank hold LVACU as of Q3 2022.

  • Calamos Advisors reported no remaining LAVA Medtech Acquisition Corp. Unit position as of Q3 2022 after selling out during the quarter.
  • Calamos Advisors sold 25,000 LAVA Medtech Acquisition Corp. Unit shares in Q3 2022, an estimated $251K.
  • Calamos Advisors first reported a position in LAVA Medtech Acquisition Corp. Unit in Q4 2021 and held it in 3 quarters.
  • Calamos Advisors's LAVA Medtech Acquisition Corp. Unit position peaked at $262K in Q4 2021.
  • 11 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Unit as of Q3 2022.

Based on Calamos Advisors's 13F filing for Q3 2022, filed 24 Oct 2022.